Triterpenoid Therapeutics (TTX) delivers a novel and fundamentally different new approach for use in the treatment of incurable cancers, chronic disease, and anti-viral applications using triterpenoids. Triterpenoids occur naturally in plants as part of their defense mechanisms. When synthetically modified become powerful regulators of oxidative stress, inflammation, and complex interactive cell networks. TTX drugs are designed to treat disease comprehensively. Targeting cellular networks and tumor micro-environments through novel mechanisms of action reducing the inflammation and oxidative stress which accompany disease. They also show promise by enhancing the ability of existing standards of care to overcome resistance. Join us in treating the untreatable.